The preference for semaglutide (43.8%) and tirzepatide (26.6%) in this study mirrors the trends in [27], which found semaglutide use in 45% of participants and tirzepatide in 28%
Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial
RELATED: Eating Enough Protein
GLP-1 medications are suitable for adults looking to manage weight, reduce cravings, and improve metabolic health
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA)
Due to the variability in response and other factors, finding new, more effective interventions is always a worthwhile effort. Jennifer Cheng, DO, chief of endocrinology at Hackensack Meridian Jersey Shore University Medical Center in New Jersey, agreed that obesity and weight loss are multifactorial, and there is still research needed to help determine who will be successful in weight loss and who will not respond